Navigation Links
BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
Date:4/15/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, April 15 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) has reviewed data from the Company's on-going MAESTRO-03 U.S. pivotal phase III clinical trial of MBP8298 for the treatment of secondary progressive MS and recommended that the trial continue.

This was the second of several regularly scheduled reviews by the DSMB that will occur over the duration of the trial. The purpose of the DSMB is to provide objective, independent safety monitoring of the trial.

To date, more than 65% of the total number of required patients have been enrolled in the Company's MAESTRO-03 clinical trial, with full enrollment anticipated for the end of the first half of 2008.

About MAESTRO-03

----------------

The MAESTRO-03 U.S. pivotal phase III clinical trial is a randomized, double-blind study enrolling approximately 510 patients at more than 60 clinical sites who will be administered either MBP8298 or placebo intravenously every six months for a period of two years. The primary clinical endpoint for the trial is defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded Disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes (up to 75% of all MS patients are HLA-DR2 and/or HLA-DR4 positive).

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMS Medical to present at BioCentury Conference
2. BioMS Medical Announces 2007 Year End Results
3. BioMS Medical to present at BIO CEO & Investor Conference
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medical announces third quarter 2007 results
8. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
9. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. BioMS Medical to present at BioContact 2007
11. BioMS Medical announces its intention to renew a normal course issuer bid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... --  Sterne, Kessler, Goldstein & Fox P.L.L.C. , an ... , announced today that it has filed eleven ... the U.S. Patent and Trademark Office (USPTO) on behalf ... (Nasdaq: BRLI).  These IPR petitions aim to nullify eleven ... These patents have been asserted against GeneDx in patent ...
(Date:8/18/2014)... Global HIV Infection Drug Market and Pipeline Insight ... of HIV infection and the number of deaths due to ... rate across the globe. It has been estimated that the ... in 2013, with the rates for children being even much ... infection rates has been the improved access to antiretroviral drugs ...
(Date:8/18/2014)... , August 18, 2014 ... Bioreactor Systems Market, By Application (Municipal Wastewater Treatment ... Flat Sheet and Multi Tubular), By Configuration (Internal/Submerged ... 2019", published by MarketsandMarkets, The market for membrane ... by 2019, growing at a CAGR of 15.28% ...
(Date:8/18/2014)... 18, 2014 Dyadic International, Inc. ("Dyadic") ... and proprietary technologies are used to develop, manufacture ... bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, ... Statement on Form 10 with the U.S. Securities ... - http://photos.prnewswire.com/prnh/20110621/CL06708LOGO The ...
Breaking Biology Technology:Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Dyadic International Files Form 10 Registration Statement 2Dyadic International Files Form 10 Registration Statement 3Dyadic International Files Form 10 Registration Statement 4
... outstanding share of common stock of Bruker AXS will be ... common stock of Bruker Daltonics or, at the election of ... value, payable 75% in Bruker Daltonics common stock and 25% ... are not being changed in the merger. , ,The combined ...
... labs, technology, research, communication and planning , ,WASHINGTON ... the Department of Health and Human Services has made ... of states, territories and metro areas to respond to ... to receive $25 million, of which almost $16 Million ...
... and Human Services announced last week the development of ... Emerging Infectious Diseases Research. The University of Wisconsin-Madison is ... Midwestern center as part of a $350 million national ... Chicago and Northwestern University will receive $35 million in ...
Cached Biology Technology:Bruker Daltonics and Bruker AXS Announce Merger Agreement 2Wisconsin to Receive $25 Million for Bioterrorism 2UW-Madison Gets Federal Biodefense Funds 2
(Date:8/18/2014)... 2014 Researchers at UT Southwestern Medical Center have found ... a type of molecule known as long non-coding RNA. , ... "rhythms" of many bodily functions, from waking and sleeping to ... 24-hour cycle that is influenced by external cues such as ... RNAs are abundant in many organisms, what they do in ...
(Date:8/18/2014)... indicates older species of coral have more of what ... climate, according to biologists from the University of Texas ... Mayagez., The researchers examined 140 samples of 14 species ... open-access journal PLOS ONE on Aug. 18. ... the UT Arlington Department of Biology, is lead author ...
(Date:8/18/2014)... kill its ant hosts outside their nest to reproduce ... in the vicinity of the colony, ensuring a constant ... Penn State and colleagues at Brazil,s Federal University of ... Previous research shows that Ophiocordyceps camponoti-rufipedis , known ... carpenter ant workers -- Camponotus rufipes -- ...
Breaking Biology News(10 mins):Researchers obtain key insights into how the internal body clock is tuned 2Researchers obtain key insights into how the internal body clock is tuned 3Older coral species more hardy, UT Arlington biologists say 2Zombie ant fungi manipulate hosts to die on the 'doorstep' of the colony 2Zombie ant fungi manipulate hosts to die on the 'doorstep' of the colony 3
... it possible to solve climate change, reduce poverty and save ... dream, but this is exactly the issue that is being ... Bali 3-14 December 2007. The key is to include reduced ... so that developing countries can be compensated for saving their ...
... Topics include: onset of plate tectonics on Earth; Arctic ... the end-Permian mass extinction; Olduvai Basin lake cycles and ... the break-up of Rodinia; relationship between earthquakes and melting ... and cause of the end of the PETM. The ...
... frogs can be crowded out by immigrant or imported ... The scientists investigated water frog populations in France and ... ridibunda), which normally occurs only in Eastern Europe, has ... hybrid frog (Rana grafi) and the Iberian water frog ...
Cached Biology News:Having the climate cake and eating it, too 2December GEOLOGY and GSA TODAY media highlights 2December GEOLOGY and GSA TODAY media highlights 3December GEOLOGY and GSA TODAY media highlights 4December GEOLOGY and GSA TODAY media highlights 5December GEOLOGY and GSA TODAY media highlights 6December GEOLOGY and GSA TODAY media highlights 7December GEOLOGY and GSA TODAY media highlights 8December GEOLOGY and GSA TODAY media highlights 9December GEOLOGY and GSA TODAY media highlights 10Indigenous water frogs under threat 2
...
... measures NOS activity by monitoring the conversion ... is simple, sensitive, and specific for NOS ... crude and purified enzyme preparations. The kit ... total reactions. Radiolabeled arginine and NADPH are ...
Human TSLP MAb (Clone 258136)...
Human Complement Component C5a MAb (Clone 295003)...
Biology Products: